Invasive cervical cancer audit: Why cancers developed in a high-risk population with an organised screening programme

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 6, 2010, Pages 736-745

  Herbert, A ^a   Anshu, ^a   Culora, G ^a   Dunsmore, H ^b   Gupta, S S ^c   Holdsworth, G ^d   Kubba, A A ^b   McLean, E ^a   Sim, J ^a   Raju, K S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^d Southwark Primary Care Trust   (United Kingdom)

Author keywords

Cancer audit; Cervical intraepithelial neoplasia; Interval cancer; Invasive cervical cancer; Screen detected cancer

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; CANCER STAGING; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; URBAN POPULATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; ENGLAND; FEMALE; HUMANS; MASS SCREENING; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM INVASIVENESS; RISK FACTORS; URBAN HEALTH; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77950649807     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02511.x     Document Type: Article

References (31)

1. Audit of Invasive Cervical Cancers. NHSCSP Publication no. 28.
2. Wiener HG, Klinkhamer P, Schenck U, Arbyn M, Bulten J, Bergeron C, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories. Cytopathology 2007 18 : 67 78 [erratum in Cytopathology. 2007;18:207]. (Pubitemid 46496716)
3. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003 89 : 88 93. (Pubitemid 36897941)
4. Priest P, Sadler L, Peters J, Crengle S, Bethwaite P, Medley G, et al. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading. BJOG 2007 114 : 398 407.
5. Bofin AM, Nygård JF, Skare GB, Dybdahl BM, Westerhagen U, Sauer T. Papanicolaou smear history in women with low-grade cytology before cervical cancer diagnosis. Cancer Cytopathol 2007 111 : 210 216.
6. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008 100 : 622 629.
7. Herbert A, Anshu, Gregory M, Gupta SS, Singh N. Screen-detected invasive cervical cancer and its clinical significance during the introduction of organized screening. BJOG 2009 116 : 854 859.
8. Herbert A, Anshu, Gregory M, Gupta SS, Singh N. Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined. BJOG 2009 116 : 845 853.
9. Herbert A, Johnson J, Patnick J. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology. Cytopathology 1995 6 : 301 303.
10. Chamberlain J. Reasons that some screening programmes fail to control cervical cancer. IARC Sci Publ 1986 76 : 161 168.
11. Thames Cancer Registry: Cancer Inequalities in London 2000-2004.
12. Currin LG, Jack RH, Linklater KM, Mak V, Møller H, Davies EA. Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health 2009 9 : 62.
13. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004 364 : 249 256.
14. Roy M, Plante M. Pregnancies after radical trachelectomy for early-stage cervical cancer. Am J Obstet Gynecol 1998 179 : 1491 1496.
15. Herbert A, Smith JAE. Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: the yawning gap and the treatment of risk. Cytopathology 1999 10 : 161 170.
16. Office for National Statistics, Department of Health [ http://www.statistics.gov.uk/StatBase/Product.asp?vlnk=7720 ]. Accessed 2 February 2010.
17. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraintraepithelial neoplasia: meta-analysis. BMJ 2008 337 : a1284.
18. Prendiville W. The treatment of CIN: what are the risks? Cytopathology 2009 20 : 145 153.
19. Herbert A, Stein K, Bryant TN, Breen C, Old P. Relation between the incidence of invasive cervical cancer and the screening interval: is a 5 year interval too long? J Med Screening 1996 3 : 140 145.
20. DeMay RM. Cytopathology of false negatives preceding cervical carcinoma. Am J Obstet Gynecol 1996 175 : 1110 1113.
21. Womack C, Warren AY. Problems with audit in cervical cytology. Cytopathology 2000 11 : 200 201.
22. Mitchell H, Medley G, Giles G. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s. BMJ 1990 300 : 1622 1626.
23. O'Sullivan JP, A'Hern RP, Chapman PA, Jenkins L, Smith R, al-Nafussi A, et al. A case-control study of true-positive versus false-negative cervical smears in women with cervical intraepithelial neoplasia (CIN) III. Cytopathology 1998 9 : 155 161.
24. Coleman DV, Poznansky JJ. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications. Cytopathology 2006 17 : 127 136.
25. Davey E, d'Assuncao J, Irwig L, Macaskill P, Chan SF, Richards A, et al. Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ 2007 335 : 31.[Epub ahead of print 2007 Jun 29 T, Middleton M, Chandra A, Culora G, Herbert A ThinPrep Imager system for internal quality control - a preliminary audit of our experience. Cytopathology 2008 19 (Suppl. 2 1 20 (abstract).
26. Jastania R, Geddie WR, Chapman W, Boerner S. Characteristics of apparently false-negative digene hybrid capture 2 high-risk HPV DNA testing. Am J Clin Pathol 2006 125 : 223 228.
27. Herbert A, Bergeron C, Wiener H, Schenck U, Klinkhamer P, Bulten J, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology 2007 18 : 213 219. (Pubitemid 47076369)
28. Denton KJ, Herbert A, Turnbull LS, Waddell C, Desai MS, Rana DN, et al. The revised BSCC terminology for abnormal cervical cytology. Cytopathology 2008 19 : 137 157.
29. Gornall RJ, Boyd IE, Manolitsas T, Herbert A. Interval cervical cancer following treatment for cervical intraepithelial neoplasia. Int J Gynecol Cancer 2000 10 : 198 202.
30. Flannelly G, Bolger B, Fawzi HD, De Lopes AB, Monaghan JM. Follow-up after LLETZ: could schedules be modified according to risk of recurrence. BJOG 2001 108 : 1025 1030.
31. Tidbury P, Singer A, Jenkins D. CIN3: the role of lesion size in invasion. Br J Obstet Gynaecol 1992 97 : 583 586.